Comparative proteome analysis of Brucella melitensis vaccine strain Rev 1 and a virulent strain, 16M

Michel Eschenbrenner1, Mary Ann Wagner, Troy A Horn

  • 1Institute of Molecular Biology and Medicine, The University of Scranton, Scranton, Pennsylvania 18510, USA.

Journal of Bacteriology
|August 24, 2002
PubMed

Insights

Brucella melitensis vaccine strain Rev 1 shows altered protein expression compared to virulent strain 16M, potentially explaining differences in virulence. This proteomic analysis offers insights into Brucella pathogenesis.

Area of Science:

  • Microbiology
  • Proteomics
  • Pathogen analysis

Background:

  • Brucella are bacterial pathogens causing brucellosis, a significant zoonotic disease.
  • Brucella melitensis is a highly virulent species, and its vaccine strains can remain infectious in humans.
  • Understanding virulence mechanisms is crucial for developing safer vaccines and treatments.

Purpose of the Study:

  • To compare the proteomes of Brucella melitensis vaccine strain Rev 1 and virulent strain 16M.
  • To identify differentially expressed proteins and understand virulence mechanisms in B. melitensis.

Main Methods:

  • Two-dimensional gel electrophoresis (2D-PAGE) for proteome analysis.
  • Peptide mass fingerprinting for protein identification.
  • Computer-assisted analysis of proteomic data.

Main Results:

  • Significant differences in protein expression were observed between B. melitensis Rev 1 and 16M strains.
  • Proteins involved in iron acquisition, sugar binding, lipid degradation, and amino acid binding showed altered expression in Rev 1.
  • An immunogenic 31-kDa outer membrane protein was differentially expressed.
  • Metabolic pathways may be deregulated in the vaccine strain.

Conclusions:

  • Proteomic differences between B. melitensis vaccine and virulent strains provide insights into virulence mechanisms.
  • Altered expression of specific proteins, including those involved in nutrient acquisition and outer membrane structure, may contribute to virulence variations.
  • Further research into these differentially expressed proteins could inform the development of improved Brucella vaccines.

Related Concept Videos